Top in GI: RHB-102 for IBS-D, ASGE campaign highlights

RHB-102 was safe and improved stool consistency in patients with diarrhea-predominant irritable bowel syndrome, or IBS-D, according to a recent study. It was the top story in gastroenterology last week.

Another top story was about a new campaign from the American Society for Gastrointestinal Endoscopy (ASGE) that aims to raise awareness about the potential life-saving benefit of colonoscopy procedures and the importance of keeping up to date with screening.

Read these and more top stories in gastroenterology below:

RHB-102 improves stool consistency in patients with IBS-D

In men and women with IBS-D, once-daily RHB-102 (Bekinda, RedHill Biopharma) was an effective and safe treatment, according to a study published in the American Journal of Gastroenterology. Read more.

VIDEO: ASGE campaign highlights ‘The Value of Colonoscopy’

In this exclusive video, Jennifer Christie, MD, from the Emory School of Medicine, and Douglas K. Rex, MD, from Indiana University School of Medicine, discuss ASGE’s campaign, “The Value of Colonoscopy.” Read more.

Entyvio, Remicade effective in checkpoint inhibitor-induced enterocolitis

Remicade (infliximab, Janssen) and Entyvio (vedolizumab, Takeda) were effective for the treatment of patients with checkpoint inhibitor-induced enterocolitis, according to the results of a meta-analysis. Read more.

Acid exposure reflux monitoring predicts PPI discontinuation in GERD

Acid exposure reflux monitoring predicted the ability to discontinue proton pump inhibitor use without symptom escalation among patients with gastroesophageal reflux disease and inadequate proton pump inhibitor response. Read more.

Bariatric surgery: ‘Invaluable tool’ for complications of obesity

Bariatric surgery can be an invaluable tool for managing the myriad complications of obesity such as diabetes, fatty liver disease, hypertension, hyperlipidemia, gastroesophageal reflux and obstructive sleep apnea. Read more.